Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MEDI 3414

Drug Profile

MEDI 3414

Alternative Names: Live attenuated nasal spray vaccine for H1N1 - MedImmune; MEDI-3414; Monovalent live attenuated pandemic influenza vaccine - MedImmune; Pandemic flu vaccine - MedImmune; Pandemic H1N1 influenza vaccine - MedImmune; Pandemic vaccines - MedImmune/NIAID

Latest Information Update: 16 Feb 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MedImmune; National Institute of Allergy and Infectious Diseases
  • Developer MedImmune
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 15 Sep 2009 Registered for prevention of Influenza-A virus H1N1 subtype in USA (Intranasal)
  • 15 Sep 2009 Interim immunogenicity & adverse events data from clinical trials in volunteers released by the US FDA
  • 19 Feb 2008 Preclinical development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top